期刊文献+

新桥医院1230例肺癌患者多因素预后分析 被引量:7

Prognostic factors of patients with lung cancer:retrospective analysis of 1 230 cases in Xinqiao Hospital
下载PDF
导出
摘要 目的通过对大样本肺癌资料的多因素预后分析,建立具有临床实用价值的预后模型,为肺癌防治提供科学依据。方法对新桥医院1999年1月1日~2004年1月1日期间具有明确组织学类型和病理分期的1230例肺癌患者,经壹阅病历并随访,回顾性分析、比较影响肺癌患者生存的预后因素。结果共随访1230例患者,失访99人,失访率8%;有效病例1131例。Cox单因素及多因素分析表明:家破史、病理分期、手术类型、化疗方案是否含铀剂及其周期是独立的影响肺癌患者预后的因素。结论家族史、病理分期、手术类型,是否合铂剂方案化疗及其周期是独立影响肺癌患者预后的因素。 Objective To analyze the prognostic factors of lung cancer,and to find some clues for prevention and a clinic treatment of lung cancer in future. Methods The data of 1 230 hospitalized patients with lung cancer in Xinqiao Hospital from January 1, 1999 to January 1,2004 were reviewed and followed up. The factors which might impact on the patients' prognosis were analyzed including general information of the patients themselves, the tumor data,and different treatment manners. Results A total of 1 230 cases were enrolled in this ,study and 1131 of them were followed up to the end-point of the study with 8%(99 cases) of loss to follow-up. Cox regression indicated that family history, tumor stage, operation manner, application of platinum-based chemotherapy and its cycles were independent prognostic factors of patients with lung cancer. Conclusion Tumor family history, tumor stage, operation manner, application of platinum-based chemotherapy and its cycles are independent prognostic factors of lung cancer patients,
出处 《重庆医学》 CAS CSCD 2006年第23期2131-2133,共3页 Chongqing medicine
基金 重庆市自然科学基金重点项目(CSTC 2005BA5006)
关键词 肺癌 预后 随访 回顾性分析 5年生存率 lung cancer prognostic factor follow- up retrospective analysis five year-survival rate
  • 相关文献

参考文献13

  • 1刘顺寿,魏峰,罗全.1667例肺癌外科治疗的多因素预后分析[J].实用肿瘤学杂志,2003,17(1):34-36. 被引量:8
  • 2Tien H,Kyung MK,Anthony J,et al.Phase Ⅱ study of second-line gemcitabine in sensitive or refractory small cell lung cancer[J].J Lung Cancer,2003,42 (1):97
  • 3Demant P.Cancer susceptibility in the mouse:genetics,biology and implications for human cancer[J].Nat Rev Genet 4,2003,128(2):721
  • 4Dragani TA.10 years of mouse cancer modifier loci:human relevance[J].Cancer Res,2003,63 (3):3011
  • 5Li X,Hemminki K.Inherited predisposition to early onset lung cancer according to histological type[J].Iht J Cancer,2004,112(3):451
  • 6Elite S,Radzikows K,Kazimier Z.Lung cancer in patients under 50 years old Elites[J].Lung Cancer,2001,33(2-3):203
  • 7Masayoshi Ⅰ,Noriyoshi S,Shinichi T,et al.Results of surgical intervention for p-stage ⅢA (N2) non-small cell lung cancer:acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe[J].J Thorac Cardiovasc Surg,2004,127(4):1100
  • 8Shib M,Kohno H,Kakizaw K,et al.Ki67 immuno staining and other prognostic factors including tobacco smoking in patients with resected NSCLC[J].Lung Cancer,2000,89(7):457
  • 9谢启超,胡义德,陈正堂.GP和NP方案治疗晚期非小细胞肺癌的疗效比较研究[J].重庆医学,2004,33(7):991-993. 被引量:3
  • 10Chevalier L,Soria JC.Status and trends of chemotherapy for advanced NSCLC[J].Eur J Cancer,2004,2 (Supp1 4):26

二级参考文献10

  • 1Vittorio Gebbia,Domenico Galetta,Fernando Riccar,et al.Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage Ⅲb/Ⅳ non small cell lung carcinoma: a prospective randomized study[J].Lung Cancer,2002,37:179
  • 2Alberola V,Camps C,Provencio M,et al.Cisplatin plus gemcitabine versus a cisplatin based triplet versus nonplatinum sequential doublets in advanced non small cell lung cancer: a Spanish Lung Cancer Group phase Ⅲ randomized trial[J].J Clin Oncol,2003,21(1
  • 3Fossella F,Pereira JR,von Pawel J,et al.Randomized multinational: phase Ⅲ study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non small cell lung cancer: the TAX 326 study group[J].J Clin Oncol,2003,21(16): 3016
  • 4Gridelli C,Gallo C,Shepherd FA,et al.Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non small cell lung cancer: a phase Ⅲ trial of the Italian GEMVIN Investigators and the National Cancer
  • 5Feliu J,Martin G,Madronal C,et al.Combination of low dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small cell lung cancer[J].Cancer Chemother Pharmacol,2003,52(3):247
  • 6Chen YM,Lee CS,Lin WC,et al.Phase II study with vinorelbine and cisplatin in advanced non small cell lung cancer after failure of previous chemotherapy[J].J Chin Med Assoc,2003,66(4):241
  • 7Miller DL, Me Manus KG, Allen MS et al. results of surgical resection in patients with N2 non - small cell lung cancer. Ann Thorac Surg 1994;57:1096 - 101.
  • 8吴一龙,黄植蕃,戎铁华,杨名添.基于97分期的非小细胞肺癌术后分期和生存研究[J].中华肿瘤杂志,1999,21(5):363-365. 被引量:75
  • 9周清华,刘伦旭,李潞,车国卫,杨俊杰,赵雍凡,陈军,王允,秦建军,侯梅,宫友陵,卢武胜,李志平.术前新辅助化疗加外科手术治疗Ⅲ期非小细胞肺癌的随机对照临床试验[J].中国肺癌杂志,2001,4(4):251-256. 被引量:101
  • 10蔡晓虹,陈萍,尹绪德,李秋.吉西他滨/卡铂和吉西他滨/顺铂方案治疗晚期非小细胞肺癌的疗效比较[J].中国肺癌杂志,2002,5(6):427-428. 被引量:12

共引文献9

同被引文献51

引证文献7

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部